Product record
Glipizide Metformin: batches declared Not of Standard Quality
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts, Jan 2019 to Sep 2026
3 batches of products named "Glipizide Metformin" (as printed by the testing lab) failed a CDSCO or state drug-testing laboratory test between June 2024 and December 2025. This is a record of specific batches, it does not mean the molecule or every brand is unsafe.
Records by type
3 records linked to Glipizide Metformin in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A failed batch is not a verdict on every pack of this product. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches
| Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Batch URDT0328Mfg Jan 2023 · Exp Dec 2025 | Unicure India LtdUttarakhand | The sample does not conform to the IP with respect to Dissolution of Glipizide.Dissolution | DTL UdaipurState lab | Dec 2025 |
| Batch Z24-011Mfg Jan 2024 · Exp Dec 2026 | Zee Laboratories LtdHimachal Pradesh | DescriptionDescription | CDTL IndoreCDSCO lab | Jun 2025 |
| Batch 4010026Mfg Nov 2023 · Exp Apr 2025 | USV Private LimitedKarnataka | Dissolution of GlipizideDissolution | CDL KolkataCDSCO lab | Jun 2024 |
How to use this. Match the batch number on your strip or bottle against the list. If your batch is listed, return it to the pharmacy and ask for a replacement; if not, the product is not on any alert as of September 2026. Check any batch number.